PRESS RELEASE Statement attributed to: Steven J. Stack, MD President, American Medical Association The American Medical Association commends the U ed treatment .S. House of Representatives because of their efforts to remove the Medicare sequester enhance and extension within the trade package. Reductions to Medicare reimbursements impact patients and providers and will reduce usage of care significantly. Medicare ought not to be used seeing that a piggybank to invest in other programs. We encourage the U.S. Senate to move expeditiously to ensure that any final trade package will not include dangerous Medicare cuts..
Today announced that the business has closed a $14 Million Series A funding round. The Company’s Hemolung device is likely to help many sufferers with acute respiratory failing to avoid intubation and invasive mechanical ventilation. This treatment is certainly expected to give a significant benefit over intubation and mechanical ventilation, for the reason that it shall permit the patient to chat and eat, and avoid sedation, while giving the lungs the opportunity to heal. Related StoriesTeva presents new Reslizumab data at European Respiratory Society International Congress 2015Study raises hope for reducing life-threatening respiratory problems in infantsPhilips showcases most recent patient-driven sleep and respiratory solutions at the European Respiratory Society International Congress 2015’This financing will allow ALung to full its clinical trial in Germany and subsequently commercialize the Hemolung System,’ said Peter DeComo, Chairman and CEO of ALung.